HPR122 Predicted vs. Actual Drug Spending for Interferon-Free Direct-Acting Antiviral Therapies in Hepatitis C: A Case Study on Drug Spending Forecasts
Abstract
Authors
Natasha Kulkarni John Jarvis Cheryl Steward Lufei Tu Alexa Klimchak Kathy Gooch Marjorie Crowell